EBAG9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.187800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.581000E-01
Normal-vs-Stage2
7.374400E-01
Normal-vs-Stage3
1.955240E-01
Normal-vs-Stage4
8.113600E-01
Stage1-vs-Stage2
5.846200E-01
Stage1-vs-Stage3
1.729370E-01
Stage1-vs-Stage4
8.015000E-01
Stage2-vs-Stage3
2.544800E-01
Stage2-vs-Stage4
4.225400E-01
Stage3-vs-Stage4
2.405800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.042800E-01
Normal-vs-AfricanAmerican
4.717800E-01
Normal-vs-Asian
6.710200E-01
Caucasian-vs-AfricanAmerican
6.621800E-01
Caucasian-vs-Asian
5.034200E-01
AfricanAmerican-vs-Asian
9.543800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.988800E-01
Normal-vs-Female
8.458400E-01
Male-vs-Female
7.386200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.794400E-01
Normal-vs-Age(41-60Yrs)
9.223800E-01
Normal-vs-Age(61-80Yrs)
6.976400E-01
Normal-vs-Age(81-100Yrs)
9.513400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.390950E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.855200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.129200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.302100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.602400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.871600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.256000E-01
Normal-vs-Daily Drinker
4.890600E-01
Normal-vs-Weekly Drinker
2.052600E-01
Normal-vs-Occasional Drinker
7.294200E-01
Normal-vs-Social Drinker
6.231600E-01
Non Drinker-vs-Daily Drinker
5.609800E-01
Non Drinker-vs-Weekly Drinker
1.427760E-01
Non Drinker-vs-Occasional Drinker
1.608970E-01
Non Drinker-vs-Social Drinker
8.953800E-01
Daily Drinker-vs-Weekly Drinker
3.029200E-01
Daily Drinker-vs-Occasional Drinker
6.567800E-02
Daily Drinker-vs-Social Drinker
6.823800E-01
Weekly Drinker-vs-Occasional Drinker
1.933570E-02
Weekly Drinker-vs-Social Drinker
1.769220E-01
Occasional Drinker-vs-Social Drinker
1.773650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.499800E-02
Normal-vs-Grade 2
1.199960E-02
Normal-vs-Grade 3
1.575930E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.185800E-01
Grade 1-vs-Grade 3
4.060800E-01
Grade 1-vs-Grade 4
5.499800E-02
Grade 2-vs-Grade 3
4.965500E-02
Grade 2-vs-Grade 4
1.199960E-02
Grade 3-vs-Grade 4
1.575930E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.761600E-01
Normal-vs-NonDiabetic
7.810400E-01
Diabetic-vs-NonDiabetic
4.322000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.373400E-01
Normal-vs-NoPancreatitis
7.866200E-01
Pancreatitis-vs-NoPancreatitis
4.124200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.269000E-01
Normal-vs-N1
7.903200E-01
N0-vs-N1
6.220600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.110000E-01
Normal-vs-TP53-NonMutant
8.513600E-01
TP53-Mutant-vs-TP53-NonMutant
7.279900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
